Title page for E-project-042507-152334

Project Type MQP

Submission date 2007-04-25

Authors
Meghan E Kelly, BIO
Shannon Leigh OConnell, BIO

URN E-project-042507-152334

Sponsor Jianhua Zhou

Title VALIDATION OF PHARMACEUTICALS LEADING TO THE REDUCTION OF INCLUSION OF TAU EXON 10

Advisor
Adams, David S., BB

Availability unrestricted

Abstract
Tau is a protein normally associated with the assembly of microtubules, but it tends to hyperphosphorylate leading to its aggregation which is a major cause of Alzheimer's disease. When alternative splicing includes tau exon 10, neurofibrillary tangles are more prevalent, so our laboratory developed a luciferase reporter assay to screen compounds that decrease tau exon 10. Prior to our project 1,040 FDA approved drugs were screened for initial luciferase activity. Our project's purpose was to further screen key five compounds identified in the original screen using the luciferase assay and RT-PCR. All five compounds tested produced statistically significant increases in luciferase activity relative to DMSO control at 5 uM concentrations, validating the original screening.

Files
MQPMS.pdf

Browse by Author | Browse by Department | Search all available E-projects

Questions? Email project-questions@wpi.edu
Maintained by webmaster@wpi.edu

Project Type	MQP
Submission date	2007-04-25
Authors	Meghan E Kelly, BIO Shannon Leigh OConnell, BIO
URN	E-project-042507-152334
Sponsor	Jianhua Zhou
Title	VALIDATION OF PHARMACEUTICALS LEADING TO THE REDUCTION OF INCLUSION OF TAU EXON 10
Advisor	Adams, David S., BB
Availability	unrestricted
Abstract Tau is a protein normally associated with the assembly of microtubules, but it tends to hyperphosphorylate leading to its aggregation which is a major cause of Alzheimer's disease. When alternative splicing includes tau exon 10, neurofibrillary tangles are more prevalent, so our laboratory developed a luciferase reporter assay to screen compounds that decrease tau exon 10. Prior to our project 1,040 FDA approved drugs were screened for initial luciferase activity. Our project's purpose was to further screen key five compounds identified in the original screen using the luciferase assay and RT-PCR. All five compounds tested produced statistically significant increases in luciferase activity relative to DMSO control at 5 uM concentrations, validating the original screening.
Files	MQPMS.pdf